Prisma Health-Upstate
prismahealth.orgTotal trials
76
Active
11
Phase 3
3
Total enrollment
10,951
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 10 of 10 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Methocarbamol | — | — | — | — | — | 1 | |
| Standard Opioid | — | — | — | — | — | 1 | |
| Standard opioid plus methocarbamol | — | — | — | — | — | 1 | |
| Acetazolamide 500 MG Extended Release Oral | — | — | — | — | — | 1 | |
| Intracervical injection of Vasopressin | — | — | — | — | — | 1 | |
| Intracervical Injection of saline | — | — | — | — | — | 1 | |
| antibiotic rinse with suction | — | — | — | — | — | 1 | |
| Sweet-cooling | — | — | — | — | — | 1 | |
| Sweet non-cooling EC flavor | — | — | — | — | — | 1 | |
| Tobacco flavor EC | — | — | — | — | — | 1 |
Next readouts
- 2026-05
- 2026-06
- 2026-08-01
- 2026-08-01
- 2026-12
Top conditions
- Cancer5
- Hepatitis C4
- Ventral Hernia4
- Substance Use Disorders3
- Opioid Use Disorder3
- Pain2
- Medication Adherence2
- Standard of Care2
Frequently asked questions about Prisma Health-Upstate
- How many clinical trials does Prisma Health-Upstate have on ClinicalTrials.gov?
- Prisma Health-Upstate is listed as the lead sponsor on 76 clinical trials in ClinicalTrials.gov, 11 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Prisma Health-Upstate's trials are in Phase 3?
- 3 of Prisma Health-Upstate's trials are in Phase 3, spread across 10 active drug programs.
- What therapeutic areas does Prisma Health-Upstate focus on?
- Prisma Health-Upstate's most-studied conditions on ClinicalTrials.gov are Cancer, Hepatitis C, Ventral Hernia, Substance Use Disorders, Opioid Use Disorder.
- When are Prisma Health-Upstate's next clinical trial readouts?
- Prisma Health-Upstate has 5 upcoming primary-completion readouts tracked here; the soonest is “Effects of E-Cigarette Flavors on Adult E-Cigarette Users With Opioid Use Disorder”, expected around 2026-05.